-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
No data
undefined
Cardiovascular system
Theophylline sustained-release tablets
[Generic Name] Theophylline Sustained-Release Tablets
[Approval Number] National Drug Approval Number H20233310
【Specification】0.4g × 10 tablets/box
[Packaging Material] Aluminum-plastic blister pack
【Dosage Form】Tablets
Theophylline sustained-release tablets
[Generic Name] Theophylline Sustained-Release Tablets
[Approval Number] National Drug Approval Number H20233310
【Specification】0.4g × 10 tablets/box
[Packaging Material] Aluminum-plastic blister pack
【Dosage Form】Tablets
Felodipine sustained-release tablets
[Generic Name] Felodipine Sustained-Release Tablets
[Approval Number] National Drug Approval Number H20223964
[Specification] 5mg × 24/box, 5mg × 48/box
[Packaging Material] Aluminum-plastic blister pack
【Dosage Form】Tablets
Felodipine sustained-release tablets
[Generic Name] Felodipine Sustained-Release Tablets
[Approval Number] National Drug Approval Number H20223964
[Specification] 5mg × 24/box, 5mg × 48/box
[Packaging Material] Aluminum-plastic blister pack
【Dosage Form】Tablets
Theobromine Injection for Ketones
[Generic Name] Theophylline Injection
[Approval Number] National Drug Approval No. H20223704
【Specification】5 ml: 0.1 g
[Packaging Material] Polypropylene Ampoule
【Dosage Form】Injection
Theobromine Injection for Ketones
[Generic Name] Theophylline Injection
[Approval Number] National Drug Approval No. H20223704
【Specification】5 ml: 0.1 g
[Packaging Material] Polypropylene Ampoule
【Dosage Form】Injection
Valsartan Amlodipine Tablets (I)
[Generic Name] Valsartan Amlodipine Tablets (I)
[Approval Number] National Drug Approval Number H20223692
[Specification] 3 ml: 0.5 g, 6 ml × 1 g
[Packaging Material] Aluminum-plastic blister pack
【Dosage Form】Tablets
Valsartan Amlodipine Tablets (I)
[Generic Name] Valsartan Amlodipine Tablets (I)
[Approval Number] National Drug Approval Number H20223692
[Specification] 3 ml: 0.5 g, 6 ml × 1 g
[Packaging Material] Aluminum-plastic blister pack
【Dosage Form】Tablets
Shanhe Oral Liquid
[Generic Name] Shanhe Oral Liquid
[Approval Number] National Drug Approval No. B20020373
[Specification] 10 ml × 10 vials/box × 80 boxes/carton
[Packaging Material] Glass Bottle
Shanhe Oral Liquid
[Generic Name] Shanhe Oral Liquid
[Approval Number] National Drug Approval No. B20020373
[Specification] 10 ml × 10 vials/box × 80 boxes/carton
[Packaging Material] Glass Bottle
Rosuvastatin Calcium Tablets
[Generic Name] Rosuvastatin Calcium Tablets
[Approval Number] National Drug Approval Number H20203427
【Specifications】10mg × 28 tablets; 10mg × 14 tablets
[Packaging] Double-aluminum packaging
[Medical Insurance] National Medical Insurance Category B
Rosuvastatin Calcium Tablets
[Generic Name] Rosuvastatin Calcium Tablets
[Approval Number] National Drug Approval Number H20203427
【Specifications】10mg × 28 tablets; 10mg × 14 tablets
[Packaging] Double-aluminum packaging
[Medical Insurance] National Medical Insurance Category B
Cyclic Adenosine Monophosphate Injection
[Generic Name] Adenosine Cyclophosphate Injection
[Approval Number] National Drug Approval Number H20051363
[Specification] 2 ml: 20 mg
[Packaging Material] Glass Ampoule
[Medical Insurance] National Medical Insurance Category B
Cyclic Adenosine Monophosphate Injection
[Generic Name] Adenosine Cyclophosphate Injection
[Approval Number] National Drug Approval Number H20051363
[Specification] 2 ml: 20 mg
[Packaging Material] Glass Ampoule
[Medical Insurance] National Medical Insurance Category B
Citicoline Sodium Glucose Injection
[Generic Name] Sodium Citicoline Glucose Injection
[Approval Number] National Drug Approval No. H20067942
[Specification] 100mL: Sodium Citicoline 0.25g and Glucose 5.0g
[Packaging Material] Glass Bottle
[Medical Insurance] National Medical Insurance Category B
Citicoline Sodium Glucose Injection
[Generic Name] Sodium Citicoline Glucose Injection
[Approval Number] National Drug Approval No. H20067942
[Specification] 100mL: Sodium Citicoline 0.25g and Glucose 5.0g
[Packaging Material] Glass Bottle
[Medical Insurance] National Medical Insurance Category B
Theophylline Sodium Chloride Injection for Ketone
[Generic Name] Theophylline Sodium Chloride Injection
[Approval Number] National Drug Approval No. H20068082
【Specification】100 ml: Theophylline 0.1 g and Sodium Chloride 0.9 g
[Packaging Material] Non-PVC soft bag/PP bottle
Theophylline Sodium Chloride Injection for Ketone
[Generic Name] Theophylline Sodium Chloride Injection
[Approval Number] National Drug Approval No. H20068082
【Specification】100 ml: Theophylline 0.1 g and Sodium Chloride 0.9 g
[Packaging Material] Non-PVC soft bag/PP bottle
SERVICE HOTLINE
Mobile site
E code
